Tag: Bristol-Myers Squibb
UK–US pharma policies and US manufacturing shape global investment strategies, says...
Ministers have already cited multi-billion-pound commitments from Moderna, Bristol Myers Squibb, and BioNTech as evidence that tariff certainty and pricing reforms are strengthening confidence in the UK as an R&D and manufacturing base.
Syngene International extends long-term research collaboration with Bristol Myers Squibb until...
The expansion of this collaboration marks the next phase of growth, reinforcing Syngene’s position as a strategic partner delivering integrated, end-to-end scientific and manufacturing solutions
Bristol Myers Squibb launches Mosaic: Signals a new era for tech-accelerated...
Demonstrates leadership in AI driven pharma through Accenture partnership
Bristol Myers Squibb launches Kopozgo in India for treatment of symptomatic...
Kopozgo is the first and only cardiac myosin inhibitor that specifically targets the underlying pathophysiology of obstructive HCM in India
CAR-T cell therapies to pave way for drug-free remission in lupus...
he early results from BMS and Cabaletta Bio highlight the transformative potential of CAR T cell therapies for severe autoimmune diseases
Syngene International to acquire stake in O2 Renewable Energy II
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
USFDA approves expanded use of Bristol Myers immunotherapy for cancer
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
QuintilesIMS led alliance to generate insights on usage of anti-cancer therapies
QuintilesIMS has formed new collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to addresses information gaps on actual utilization of anti-cancer therapies....